Apiam Animal Health Limited announced the appointment of Professor Jan Tennent as a Non-Executive Director of the company, effective from 1 August 2018. Jan has extensive experience and is an internationally-recognised specialist in technical knowledge of antibiotic resistance mechanisms and the discovery and commercialization of vaccines (biologicals) to prevent infectious diseases through stimulation of protective immune responses. She is currently the CEO of Bio21 Australia Limited (t/a Biomedical Research Victoria) and serves as a non-executive director of AusBiotech Limited and David J. Curnow Pty Ltd. and is a member of the Industry Advisory Board of the Medicines Manufacturing Innovation Centre, Monash University. Jan is also the founder and principal of ConnectBio consultancy.